---
title: "CSPC Pharmaceutical receives USD 10 million AstraZeneca milestone payment under research pact"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294943932.md"
description: "CSPC Pharmaceutical received a USD 10 million milestone payment from AstraZeneca on August 5, 2026. This payment was triggered by AstraZeneca exercising a license option for one preclinical candidate program under their strategic research collaboration agreement."
datetime: "2026-08-05T09:51:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294943932.md)
  - [en](https://longbridge.com/en/news/294943932.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294943932.md)
---

# CSPC Pharmaceutical receives USD 10 million AstraZeneca milestone payment under research pact

-   CSPC received a USD 10 million milestone payment from AstraZeneca on Aug. 5, 2026 under their strategic research collaboration. \* Payment followed AstraZeneca’s exercise of a license option for one preclinical candidate program. \* Collaboration covers discovery of oral small-molecule preclinical candidates across multiple targets. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CSPC Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260805-12273585), on August 05, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [01093.HK](https://longbridge.com/en/quote/01093.HK.md)
- [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md)
- [00388.HK](https://longbridge.com/en/quote/00388.HK.md)
- [80388.HK](https://longbridge.com/en/quote/80388.HK.md)
- [HKXCY.US](https://longbridge.com/en/quote/HKXCY.US.md)

## Related News & Research

- [CSPC Pharma, AstraZeneca form biologics manufacturing JV in China with 51%-49% split](https://longbridge.com/en/news/294932947.md)
- [Why Is Bristol-Myers Squibb Stock Surging Monday?](https://longbridge.com/en/news/294697898.md)
- [An AstraZeneca, Bristol Myers Squibb merger could create a cancer-drug giant, but analysts call it 'odd'](https://longbridge.com/en/news/294738560.md)
- [CSPC Pharma says China clears clinical trial for RSV vaccine candidate SYS 6057](https://longbridge.com/en/news/294492639.md)
- [AstraZeneca in talks over £300bn mega-merger with US rival – reports](https://longbridge.com/en/news/294669830.md)